Semi-Annual Consolidated Statement Of Comprehensive Income

Carna Biosciences, Inc. - Filing #7272198

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-2,168,495,000 JPY
-2,178,576,000 JPY
-2,168,495,000 JPY
-2,168,495,000 JPY
-2,168,495,000 JPY
-1,184,953,000 JPY
-1,184,953,000 JPY
-1,152,895,000 JPY
-1,184,953,000 JPY
-1,184,953,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-707,000 JPY
-349,000 JPY
Deferred gains or losses on hedges
JPY
-615,000 JPY
Foreign currency translation adjustment
34,637,000 JPY
18,483,000 JPY
Other comprehensive income
33,929,000 JPY
17,518,000 JPY
Comprehensive income
-2,144,646,000 JPY
-1,135,377,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-2,144,646,000 JPY
-1,135,377,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.